<DOC>
	<DOCNO>NCT00250133</DOCNO>
	<brief_summary>Selective decontamination digestive tract ( SDD ) prophylactic measure aim reduce Gram negative flora gut aim reduce nosocomial infection ventilator-associated pneumonia . A recent large randomize trial Netherlands show SDD use associate reduced mortality ICU . Theoretically , SDD may select Gram positive organism MRSA VRE . This observe Dutch study , rate MRSA VRE low hospital Netherlands . Fears selection MRSA VRE limit application SDD United States . In pilot study , 40 patient transplant intensive care unit ( SDD use intermittently least 10 year ) , randomize SDD SDD . These patient know VRE positive baseline . The effect SDD density VRE stool day 7 compare pre-SDD primary endpoint . Secondary endpoint detection MRSA colistin resistant Pseudomonas stool .</brief_summary>
	<brief_title>Microbiologic Effect Selective Decontamination Digestive Tract With Colistin , Gentamicin Nystatin</brief_title>
	<detailed_description>Study Design We enroll 40 consecutive patient VRE colonization admit Transplant ICU Montefiore Hospital . Methods : A total 40 patient randomize SDD SDD Investigational Drugs Service Pharmacy . No placebo use assign receive SDD . Patients either receive standard care standard care + SDD . No treatment kind withhold participant . Enrolled patient know colonized VRE ( obtain inform consent patient patient ' proxy ) . SDD give enterally nasogastric tube clamp 1 hour . SDD stop patient extubated . Otherwise SDD give 7 day . Day 1 patient start SDD consist colistin 100 mg , gentamicin 80mg , nystatin 2 million/U 23mL . It give every 6 hour via nasogastric tube nasogastric tube clamp 1 hour . Stool collect day baseline ( pre administration SDD ) , day 4 , 7 14 quantitative culture resistant pathogens stool . VRE , MRSA Pseudomonas aeruginosa seek . An endotracheal aspirate day also collect day ( baseline , 1 , 4 , 7 , 14 ) qualitative culture presence MRSA Pseudomonas aeruginosa . If bowel movement day stool collect , sample obtain . In addition , endotracheal tube pull , endotracheal aspirate obtain . Samples obtain available . In addition , woman child bear potential ( female biologically capable become pregnant ) , small sample ( 1 teaspoonful ) blood take vein subject 's arm pregnancy test , prior study drug administration . Pregnant woman , woman currently breast-feeding infant , allow take part study . The primary microbiologic endpoint measurement fecal density VRE day 7 , comparison measurement day 1 . Secondary endpoint change VRE fecal density baseline day 14 , change MRSA fecal density baseline day 14 , presence colistin resistant Pseudomonas stool endotracheal aspirate day 14 . The following information also collect : Demographic data ( address , date birth , etc . ) include age , sex , height , weight , state birth , previous report associate participant 's condition , laboratory result , current medication use , prior medical problems/history . This information obtain medical record and/or subject become part research record . Sample storage organism The biologic sample ( organism ) control principal investigator research project . To protect confidentiality , personal identifier ( i.e. , name , social security number , birth date ) remove ( de-identified ) replace specific code number . The information link code number correspond subject ' identity keep separate , secure location . The investigator study keep sample indefinitely . The biologic sample provide Dr. Curtis Donskey , Case Western Reserve University , Cleveland , Ohio . Dr Donskey perform colony count sample order determine density organisms sample , use method describe work publish New England Journal Medicine ( 11 ) . All sample provide de-identified . Dr Paterson perform pulse field gel electrophoresis isolate determine isolates genotypically identical baseline post-SDD . If subject withdraws provide request writing , sample collect already process destroy . All sample keep Dr Paterson 's laboratory Scaife Hall , Room 812 , 3550 Terrace Street Donskey 's laboratory Cleveland Veterans Affairs Medical Center , East Avenue , Cleveland OH .</detailed_description>
	<mesh_term>Colistin</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Nystatin</mesh_term>
	<criteria>Patients ICU identify VRE colonization Infection Control 's surveillance swab presence VRE clinical specimen . Patients must &gt; 18 year age . Patients expectation least 4 day mechanical ventilation . Presence nasogastric enteral feeding tube . Written informed consent patient proxy . Exclusion criterion : Allergy colistin , gentamicin nystatin . Pregnancy . Intestinal transplant multivisceral transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>selective decontamination digestive tract</keyword>
</DOC>